Stay updated with breaking news from Cell Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a health breakthrough, scientists at the UC Davis Comprehensive Cancer Center in Sacramento, California, have identified a protein on the CD95 receptor that can “program" cancer dells to die.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.